ISoP Africa Chapter Meeting

The event is expired

The Africa Chapter of the International Society of Pharmacovigilance (ISoP) is organizing its first in-person meeting since its inauguration in 2019. The Theme of the meeting is “Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making.” The meeting aims to foster collaboration and knowledge exchange between members to enhance pharmacovigilance practices within the continent. With the support of partners, this event will bring together pharmacovigilance experts, regulators, and industry professionals to discuss opportunities and key challenges for enhancing patient safety in Africa. It will facilitate collaboration and knowledge exchange among stakeholders in pharmacovigilance in Africa on advancing pharmacovigilance practice and patient safety on the continent.

Tags:
08:00 - 09:00 Registration
  • Dr. Jayesh M. Pandit
  • Comfort Ogar
Session 1: Advancing PV Data-Driven Decision Making in Africa

Chairpersons

B. Pharm, M. Pharm (Pharmacy Practice), Bayer East Africa Ltd
United States Pharmacopeia
  • Kenneth Onu
09:10 - 09:30 Data Collection to Data-Driven Decision-Making for Patient Safety in Africa: A case of the AU-3S pilot during COVID-19 pandemic in promoting patient safety
Principal Programme Officer, AUDA-NEPAD
  • Mulugeta Russom
09:30 - 09:50 Role of VigiLyze for signal detection and regulatory decision making - Experiences and lessons from Eritrea
FISoP, Eritrean Pharmacovigilance Centre
  • Dr Kimberley Gutu
09:50 - 10:10 Envisioning database networks for safety surveillance in Africa - opportunities and challenges
Project Manager, Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
  • Lebogang Koitsiwe
10:10 - 10:30 Use of RWD for PV data-driven decision: Experience from Botswana
Pharmacovigilance Manager, BoMRA
  • Peter Usman Bassi
10:30 – 10:40 Oral Presentation: Impact of serious adverse drug reactions on the quality of life of patients on highly active antiretroviral therapy
University/University Teaching Hospital, Nigeria
10:40 – 10:45 Sponsor Presentation

Deirdre McCarthy, Senior Program Officer, Integrated Development, Bill & Melinda Gates Foundation

10:45 – 11:15 Coffee Break and Poster Session
  • Peter Usman Bassi
  • Mulugeta Russom
Session 2: Signal Management and Risk Communication

Chairpersons

University/University Teaching Hospital, Nigeria
FISoP, Eritrean Pharmacovigilance Centre
  • Dr Ronald Kiguba
11:20 – 11:40 The Role of Patient Reporting in Strengthening Signal Detection in PV Databases
Senior Lecturer, Makerere University
  • Mulugeta Russom
11:40 – 12:00 Eritrea experience in signal management and risk communication: success stories, challenges and lessons learned
FISoP, Eritrean Pharmacovigilance Centre
  • Jackson Mukonzo
12:00 – 12:20 The Journey from Safety Signals to Risk Factors to Product Label - A Case of Efavirenz Signal Management and Risk Communication
Associate Professor and Chair Department of Pharmacology and Therapeutics, Makerere University
  • EDITH ANDREWS ANNAN
12:20 – 12:40 Utilization and impact of the WHO Global Surveillance and Monitoring System database
Technical Officer, Medicines and Health Technologies, WHO
  • Henry Zakumumpa
12:40 – 12:50 Oral Presentation: Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in Western Uganda
Makerere University, Uganda
  • Christopher Cox
12:50 – 13:00 Oral Presentation: Signal Management and Risk Communication in Pharmacovigilance: Exploring Dynamics, Challenges, and Strategies in Uganda
Pharmacist, Mulago National Referral Hospital
13:05 – 14:00 Lunch
  • Peter Usman Bassi
  • Mulugeta Russom
Session 3: Vaccine Safety Monitoring in Africa

Chairpersons

University/University Teaching Hospital, Nigeria
FISoP, Eritrean Pharmacovigilance Centre
  • Uchenna Elemuwa
14:05 – 14:15 Enhancing Vaccine Pharmacovigilance and vaccine safety database: The role of National immunization Program
Director Pharmacovigilance, NAFDAC, Nigeria
  • Rebecca Chandler
14:15 – 14:25 Vaccine safety and pharmacovigilance within the context of CEPI’s 100 days mission
Clinical Development Vaccine Safety Lead, CEPI
  • Ombeva Malande
14:25 – 14:35 Vaccine hesitancy and the importance of safety monitoring in enhancing coverage for new vaccines
Director, ECAVI
  • Rebecca Chandler
  • Ombeva Malande
  • Hannelie Meyer
  • Uchenna Elemuwa
14:35 – 15:15 Panel Discussion: Vaccine Safety and Mitigating Vaccine Hesitancy
Clinical Development Vaccine Safety Lead, CEPI
Director, ECAVI
Professor, Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University (SMU)
Director Pharmacovigilance, NAFDAC, Nigeria
  • Damas Matiko Nyang’anyi
15:15 – 15:25 Oral presentation: Strengthening the Adverse Events Following Immunization Surveillance System for COVID-19 Vaccine Safety Monitoring and beyond: a case of Tanzania
Tanzania Medicines and Medical Devices Authority (TMDA)
  • Comfort Ogar
15:25 – 15:35 Oral presentation: Patient Reported Outcomes of Adverse Events After COVID-19 Vaccination in Nigeria: A Mixed Methods Study
United States Pharmacopeia
15:40 – 16:00 Coffee Break and Poster Session
Conference Opening Ceremony
  • Helen Ndagije
16:00 – 16:10 Remarks from the President of The ISoP Africa Chapter
PhD, FISoP, Director Product Safety Uganda National Drug Authority
  • Angela Caro Rojas
16:10 – 16:20 Remarks from the President of ISoP Global
President, International Society of Pharmacovigilance (ISoP)
16:20 – 16:30 Remarks from the Secretary to the Authority

David Nahamya, Secretary to the Authority

16:30 – 16:40 Remarks from the Chairperson of the Board NDA

Dr Medard Bitekyerezo, Chairperson Board NDA

16:40 – 16:50 Remarks from AUDA-NEPAD

Symerre Grey- Johnson, Director Human capital and institutional development, AUDA_NEPAD

16:50 – 17:00 Speech from Country representative WHO

Dr Yonas Tegegn Woldemariam, Country Representative WH

  • HON. DR. JANE RUTH ACENG OCERO
17:00 – 17:15 Opening remarks/ Speech from the minister of Health
Minister of Health, Uganda
17:15 – 17:30 Photographs
18:00 - 20:00 Drinks Reception
  • Kate Kikule
  • Victoria Prudence Nambasa
Session 4: Regulatory Harmonization for PV

Chairpersons:

Senior Principal Technical Advisor, USAID MTaPS Program
African Union Development Agency-NEPAD
  • Helen Ndagije
08:50 – 09:10 The role of ISoP in the African Medicines Agency (AMA) Pharmacovigilance Framework
PhD, FISoP, Director Product Safety Uganda National Drug Authority
  • Angela Caro Rojas
09:10 – 09:30 ISoP Strategic Vision and How to Support Africa
President, International Society of Pharmacovigilance (ISoP)
  • Vanessa Msengezi
09:30 – 09:50 Updates on Regional PV Harmonization in Africa
African Medicines Regulatory Harmonisation Programme, AUDA-NEPAD
  • Victoria Prudence Nambasa
09:50 – 10:00 Oral Presentation: Assessing the maternal vaccine pharmacovigilance landscape in Uganda
African Union Development Agency-NEPAD
  • Thuli Makhene
10:00 – 10:10 Oral Presentation: Pharmacovigilance Guideline Harmonisation in Africa
Head of PV Sub-Saharan Africa, Bayer
10:15 – 10:30 Coffee Break and Poster Session
  • Dorothy Aywak
  • NIMISHA KOTECHA
Session 5: Pharmacovigilance in Africa: A Local Perspective

Chairpersons:

Kenyatta National Hospital
Managing Director, IntuVigilance Ltd
  • Dr. Jayesh M. Pandit
10:35 – 10:55 Why is Pharmacovigilance important to Africa?
B. Pharm, M. Pharm (Pharmacy Practice), Bayer East Africa Ltd
  • Frances Philomena Namatovu
10:55 – 11:15 PV from Local Manufacturers’ Perspective
QPPV, Quality Chemical Industries Ltd
11:15 – 11:35 PV from Local Distributors’ Perspective

TBC

  • Blessed Kitentera
11:35 – 11:45 Oral Presentation: Discovering the potential of local pharmaceutical manufacturers in Africa through effective pharmacovigilance
Mbarara University, Uganda
  • Michael Muhoozi
11:45 – 11:55 Oral Presentation: A cost-effectiveness analysis of active and passive vaccinovigilance of adverse events following Measles-Rubella Immunization for Children in Eastern Uganda
Health Services Researcher
12:00 – 12:50 Lunch
  • Comfort Ogar
Session 6: Active Monitoring of Medicines / Vaccines

Chairpersons:

United States Pharmacopeia
  • Omar Aimer
12:55 – 13:15 Navigating Challenges and Successes: Leveraging New Technologies in Adverse Event Reporting in the context of active surveillance
ISoP EC member and Treasurer, NASoP President, Medical Device SIG lead.
  • Dr Edinam Agbenu
13:15 – 13:35 The role of active safety monitoring of COVID-19 vaccines in maximizing reporting and enhancing the quality of immunization campaigns – experiences from Africa
Vaccine Safety Officer, WHO Regional Office for Africa
  • Prof Bernhards Ogutu
13:35 – 13:55 Combining data from clinical trials and post-introduction active safety monitoring studies to enhance safety decision-making
Senior Clinical Scientist, KEMRI
  • Aida Hagos
13:55 – 14:05 Oral Presentation: Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance
Technical Advisor on Pharmacovigilance and Product Safety for USAID-funded PQM+ program.
  • Kato Outhman Sengendo
14:05 – 14:15 Oral Presentation: Safety Outcomes of COVID-19 Vaccines in People Living with HIV: A Prospective Cohort Study in Uganda
Infectious Diseases Institute, Uganda
  • Jonans Tusiimire
14:15 – 14:25 Oral Presentation: Building Pharmacovigilance Capacity among Health Professionals in Uganda through Curriculum Intervention
Deputy Dean Faculty of Medicine, MUST
14:30 – 14:50 Coffee Break and Poster Session
  • Kennedy Odokonyero
  • CLARICE AMBALE
Session 7: Digital Health and Patient Engagement in PV

Chairpersons:

PV Consultant
Mpharm, Centre for Health Solutions - Kenya
  • Dr Ronald Kiguba
14:55 – 15:15 Using peer support to promote patient-led digital pharmacovigilance in limited-resource settings
Senior Lecturer, Makerere University
  • Helena Sköld
15:15 – 15:35 Health Data Analytics for Pharmacovigilance in Africa
Head of VigiBase and Regulatory Services, Uppsala Monitoring Centre, Sweden
  • Mohammed Fouda
15:35 – 15:55 Artificial Intelligence in Pharmacovigilance
Head, Signal Detection Section, Saudi Food and Drug Authority
  • Mick Foy
15:55 – 16:15 Using Technology for Better Data Collection in Pharmacovigilance
Mick Foy, Director of Delivery, MHRA
  • Kudakwashe Dandajena
16:15 – 16:25 Oral Presentation: Digital Transformation Approach for African Safety Surveillance: Insights from AU-3S Programme's Deployment Towards AfriVigilance
Principal Programme Officer Technology Strategy, AUDA-NEPAD
  • Deane Putzier
16:25 – 16:35 Oral presentation: Pharmacovigilance Monitoring System PViMS (OpenRIMS-PV) – A Digital Tool to Enhance Decision-Making for Active and Passive Patient Safety Monitoring
Senior Principal Technical Advisor, MTaPS program
16:40 Transport to the Gala Dinner Venue
18:00 - 21:00 Gala Dinner
  • Victoria Prudence Nambasa
Session 8: Impact of the African genetic background on AE and future PV monitoring

Chairpersons:

African Union Development Agency-NEPAD
  • Janine Scholefield
09:35 – 09:55 Using data precision medicine solutions to address adverse drug reactions
CSIR research group leader
  • Prof Bernhards Ogutu
09:55 – 10:15 Use of local African datasets to infer and predict high-impact drug-gene pairs to monitor and minimize ADR
Senior Clinical Scientist, KEMRI
  • Eshara Chotoo
10:15 – 10:35 The Implementation of Precision Medicine, an African Agenda from a Private Sector perspective
CEO, Antares Genomics
  • Kudakwashe Dandajena
10:35 – 10:45 Oral Presentation: Digital Transformation Approach for African Safety Surveillance: Insights from AU-3S Programme's Deployment Towards AfriVigilance
Principal Programme Officer Technology Strategy, AUDA-NEPAD
  • Dan Kajungu
10:45 – 10:55 Oral presentation: Assessing the background incidence rates of adverse events of special interest in obstetric and neonatal care using the GAIA in Uganda
Makerere University Centre for Health and Population Research (MUCHAP)
  • Aston Nuwagira
10:55 – 11:05 Oral Presentation: Transitioning Children to Optimized Regimens of Pediatric Dolutegravir ( TORPEDO) Study: Pharmacovigilance Endline Results in Uganda, Nigeria and Benin
Clinton Health Access Initiative, Uganda
  • Claudia Janice Latabu
11:05 – 11:15 Oral Presentation: Strengthening Pharmacovigilance using the COM-B Model at Facilities Starting Children on Dolutegravir-based Regimens in Uganda from January 2022 to December 2022
Infectious Disease Institute, Uganda
  • Dorothy Nakanwagi
11:15 – 11:25 Oral Presentation: Increasing the proportion of correctly documented adverse drugs (ADRs) at Mulago ISS Clinic, a high volume HIV care facility in Kampala Uganda
Senior Pharmacy Technician, Makerere University
11:30 - 11:50 Coffee Break
11:50 - 12:40 ISoP Africa Chapter- Business Meeting
12:40 - 14:20 Closing Ceremony
14:20 – 15:20 Lunch
Mohammed Fouda

Mohammed Fouda

Head, Signal Detection Section, Saudi Food and Drug Authority
Blessed Kitentera

Blessed Kitentera

Mbarara University, Uganda
Janine Scholefield

Janine Scholefield

CSIR research group leader
Damas Matiko Nyang’anyi

Damas Matiko Nyang’anyi

Tanzania Medicines and Medical Devices Authority (TMDA)
Kate Kikule

Kate Kikule

Senior Principal Technical Advisor, USAID MTaPS Program
Claudia Janice Latabu

Claudia Janice Latabu

Infectious Disease Institute, Uganda
Thuli Makhene

Thuli Makhene

Head of PV Sub-Saharan Africa, Bayer
Michael Muhoozi

Michael Muhoozi

Health Services Researcher
Kennedy Odokonyero

Kennedy Odokonyero

PV Consultant
Kato Outhman Sengendo

Kato Outhman Sengendo

Infectious Diseases Institute, Uganda
Aida Hagos

Aida Hagos

Technical Advisor on Pharmacovigilance and Product Safety for USAID-funded PQM+ program.
Deane Putzier

Deane Putzier

Senior Principal Technical Advisor, MTaPS program
Christopher Cox

Christopher Cox

Pharmacist, Mulago National Referral Hospital
HON. DR. JANE RUTH ACENG OCERO

HON. DR. JANE RUTH ACENG OCERO

Minister of Health, Uganda
Dorothy Nakanwagi

Dorothy Nakanwagi

Senior Pharmacy Technician, Makerere University
EDITH ANDREWS ANNAN

EDITH ANDREWS ANNAN

Technical Officer, Medicines and Health Technologies, WHO
Jackson Mukonzo

Jackson Mukonzo

Associate Professor and Chair Department of Pharmacology and Therapeutics, Makerere University
Kudakwashe Dandajena

Kudakwashe Dandajena

Principal Programme Officer Technology Strategy, AUDA-NEPAD
Dan Kajungu

Dan Kajungu

Makerere University Centre for Health and Population Research (MUCHAP)
Eshara Chotoo

Eshara Chotoo

CEO, Antares Genomics
Frances Philomena Namatovu

Frances Philomena Namatovu

QPPV, Quality Chemical Industries Ltd
Mick Foy

Mick Foy

Mick Foy, Director of Delivery, MHRA
Helena Sköld

Helena Sköld

Head of VigiBase and Regulatory Services, Uppsala Monitoring Centre, Sweden
Vanessa Msengezi

Vanessa Msengezi

African Medicines Regulatory Harmonisation Programme, AUDA-NEPAD
Dr Edinam Agbenu

Dr Edinam Agbenu

Vaccine Safety Officer, WHO Regional Office for Africa
Dorothy Aywak

Dorothy Aywak

Kenyatta National Hospital
Peter Usman Bassi

Peter Usman Bassi

University/University Teaching Hospital, Nigeria
Victoria Prudence Nambasa

Victoria Prudence Nambasa

African Union Development Agency-NEPAD
Helen Ndagije

Helen Ndagije

PhD, FISoP, Director Product Safety Uganda National Drug Authority
Dr. Jayesh M. Pandit

Dr. Jayesh M. Pandit

B. Pharm, M. Pharm (Pharmacy Practice), Bayer East Africa Ltd
CLARICE AMBALE

CLARICE AMBALE

Mpharm, Centre for Health Solutions - Kenya
Mulugeta Russom

Mulugeta Russom

FISoP, Eritrean Pharmacovigilance Centre
NIMISHA KOTECHA

NIMISHA KOTECHA

Managing Director, IntuVigilance Ltd
Prof Bernhards Ogutu

Prof Bernhards Ogutu

Senior Clinical Scientist, KEMRI
Angela Caro Rojas

Angela Caro Rojas

President, International Society of Pharmacovigilance (ISoP)
Omar Aimer

Omar Aimer

ISoP EC member and Treasurer, NASoP President, Medical Device SIG lead.
Comfort Ogar

Comfort Ogar

United States Pharmacopeia
Dr Kimberley Gutu

Dr Kimberley Gutu

Project Manager, Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
Dr Ronald Kiguba

Dr Ronald Kiguba

Senior Lecturer, Makerere University
Hannelie Meyer

Hannelie Meyer

Professor, Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University (SMU)
Rebecca Chandler

Rebecca Chandler

Clinical Development Vaccine Safety Lead, CEPI
Lebogang Koitsiwe

Lebogang Koitsiwe

Pharmacovigilance Manager, BoMRA
Ombeva Malande

Ombeva Malande

Director, ECAVI
Kenneth Onu

Kenneth Onu

Principal Programme Officer, AUDA-NEPAD
Aston Nuwagira

Aston Nuwagira

Clinton Health Access Initiative, Uganda
Henry Zakumumpa

Henry Zakumumpa

Makerere University, Uganda
Uchenna Elemuwa

Uchenna Elemuwa

Director Pharmacovigilance, NAFDAC, Nigeria
Jonans Tusiimire

Jonans Tusiimire

Deputy Dean Faculty of Medicine, MUST
ISoP Membership
All conference participants will receive automatic ISoP membership by virtue of registering for the conference. Therefore participants should be aware that in case of cancellation, the refund will be less by the membership fee.
Low and Middle-Income country
According to the World Bank classification
Attendance at the event
This event is being organised by The Africa Chapter of International Society of Pharmacovigilance (ISoP). By completing this registration form, you confirm and acknowledge that you are attending the event in your capacity as a healthcare professional or scientist.
Early-bird rate
In order to qualify for any 'early bird' rates, booking and direct payment or a cheque must be received before the deadline date listed in the conference marketing material. Inclusive offers cannot be split between two people
How to pay?
Our preferred method of payment is credit/debit card. We accept most credit/debit cards and you will have an option to pay directly into the bank account in Uganda. It is the responsibility of the delegate to ensure payment is made. ISoP Africa Chapter will not chase sponsors or employers for payment on the delegate’s behalf. Delegates will NOT be allowed to enter the event if the registration fee is not paid in full.
Gala Dinner
Please note that there is a separate charge to attend the Gala Dinner - please indicate when making a booking. There will NO access to the dinner unless you have paid for this beforehand.
Hotel Accommodation
Hotel accommodation is NOT included in the registration fee, you will have to book that separately. We have secured some preferred rates with Speke Resort and you can book that with this link https://www.spekeresort.com/ISoP-Africa-Conference/. There are also a number of hotels close to the conference venue
Closing dates for registration
All registrations must be completed (and paid) prior to attending the conference. Please note there will NO bookings taken on site.
Substitutions & Cancellations
Delegates may nominate an alternative person from their organisation to attend up to 48 hours prior to the start of the event, at no extra charge assuming that the substitute person holds the same membership status or additional fees may be required. Should substitution not be possible, cancellation charges apply as follows: • 8 weeks or more prior to start of event: 10% of the delegate fee • 4 to 8 weeks prior to start of event: 50% of the delegate fee • 4 weeks or less prior to start of event: 100% of the delegate fee All substitutions and cancellations must be received in writing by email to [email protected]
Cancellation of the event
ISoP Africa Chapter reserves the right to postpone, alter and/or cancel all or any part of the event (including in-person day(s)) for any reason (including, without limitation, by reason of a force majeure). In the event that all or any part of the event is postponed, altered or cancelled for any reason, delegates will be notified as soon as practicable prior to the advertised dates of the event. ISoP Africa Chapter accepts no liability in respect of any loss or damage, whether direct, consequential or otherwise arising from any alteration (including, without limitation, a change to the format of delivery of the event or a change of event venue), postponement (including, without limitation, any delay in providing the event), or cancellation of the event. ISoP Africa Chapter shall not be liable to delegates for any costs incurred in connection with accessing/attending the event.
Programme and speakers
ISoP Africa Chapter reserves the right to alter the programme and/or speakers without prior notice and without any liability to delegates. ISoP Africa Chapter does not accept responsibility for the views expressed by the individual speakers. Please note that this event is kindly supported by a range of exhibitors and sponsors. ISoP Africa Chapter would like to thank the sponsors and all exhibitors for their support of the event. A full list of sponsors and exhibitors will be available on the event website. Sponsors and exhibitors have had no input into the arrangements for the event, including the agenda, content and speakers.
Photography and recordings
Photographs and video recordings may be taken and made at the conference by an official ISoP Africa Chapter photographer/ videographer. ISoP Africa Chapter may use these photos and videos in post-event publicity and on future marketing materials. In registering to attend the conference, delegates agree to the official photographer/videographer taking such photographs and videos, and to ISoP Africa Chapter using the photographs and videos as set out above. If you do not wish to be in any photography or video, you must notify a member of the ISoP Africa Chapter team immediately upon arrival at the conference for further guidance. Delegates are not permitted to make their own video or audio recordings of any part of the event or use any photographs or videos for commercial purposes, unless they have ISoP Africa Chapter’s permission. Please note: other attendees at the conference (delegates, speakers, exhibitors and sponsors etc.) may also take photographs and videos. ISoP Africa Chapter accepts no responsibility in connection with the use of these photographs or videos.
Code of conduct
Delegates must not share any event content (including satellite symposia content) or access to such content with anyone else, in particular lay persons. Delegates, including those sponsored or employed by pharmaceutical companies may not promote their sponsors and/or employers, or the products or services conducted by such sponsors and/or employers outside of their allocated exhibition stand (if relevant). This includes (without limitation) promotion by way of branded items, such as the wearing of branded clothing outside of the exhibition hall. Canvassing for orders by delegates or any unauthorised person, including the display or distribution of materials, is strictly prohibited. Canvassing is only permitted by exhibitors (on their own stands), at sponsored satellite symposia (in agreement with ISoP Africa Chapter), via official promotion options and by authorised individuals. ISoP Africa Chapter reserves the right, without any liability, to refuse a delegate access or eject them from the digital or in-person event for failure to comply with these Terms and Conditions; or if in ISoP Africa Chapter’s opinion a delegate represents a security risk, nuisance or annoyance to the running of the event. Delegates agree to follow all Covid-19 related rules and requirements imposed by ISoP Chapter Africa or the event’s venue, even where they go beyond Government guidelines.
Data protection
ISoP Africa Chapter takes data protection and your privacy seriously. We will use the personal data you provide to us to: Process your registration and provide applicable conference updates and services. We may need to share your data with third parties working for us, such as the conference venue and security providers. We will not provide or sell your personal data to other companies for marketing purposes without your agreement (see below for circumstances in which your information may be provided to sponsors or exhibitors). ISoP Africa Chapter will not take responsibility for any personal information or data you choose to share with exhibitors or delegates directly at the event.

    Event Detail

    July 22, 2024 9:00 am
    July 24, 2024 5:00 pm
    Victoria Ballroom
    Wavamunno Road, P. O. Box 446, Kampala Uganda

    Organizers

    ISoP Africa Chapter
    002560772123197
    Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making

    Sponsors